FAMOS
Functional anatomical molecular optical screening
| Coordinatore | MEDIZINISCHE UNIVERSITAET WIEN
Organization address
city: Wien contact info |
| Nazionalità Coordinatore | Austria [AT] |
| Totale costo | 13˙404˙446 € |
| EC contributo | 10˙099˙999 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2011-8 |
| Funding Scheme | CP |
| Anno di inizio | 2012 |
| Periodo (anno-mese-giorno) | 2012-10-01 - 2016-09-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
MEDIZINISCHE UNIVERSITAET WIEN
Organization address
city: Wien contact info |
AT (Wien) | coordinator | 0.00 |
| 2 |
DANMARKS TEKNISKE UNIVERSITET
Organization address
address: Anker Engelundsvej 1, Building 101A contact info |
DK (KONGENS LYNGBY) | participant | 0.00 |
| 3 |
ELFORLIGHT LIMITED
Organization address
address: BRUNEL CLOSE 4B DRAYTON FIELDS contact info |
UK (Daventry) | participant | 0.00 |
| 4 |
EXALOS AG
Organization address
address: WAGISTRASSE contact info |
CH (SCHLIEREN) | participant | 0.00 |
| 5 |
FEMTOLASERS PRODUKTIONS GMBH
Organization address
address: Kleinengerdorferstrasse contact info |
AT (KORNEUBURG) | participant | 0.00 |
| 6 |
FORSCHUNGSVERBUND BERLIN E.V.
Organization address
address: Rudower Chaussee contact info |
DE (BERLIN) | participant | 0.00 |
| 7 |
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Organization address
address: Ingolstaedter Landstrasse contact info |
DE (NEUHERBERG) | participant | 0.00 |
| 8 |
IMAGINE EYES SA
Organization address
address: RUE CHARLES DE GAULLE contact info |
FR (ORSAY) | participant | 0.00 |
| 9 |
INNOLAS LASER GMBH
Organization address
address: JUSTUS-VON-LIEBIG-RING contact info |
DE (KRAILLING) | participant | 0.00 |
| 10 |
ITHERA MEDICAL GMBH
Organization address
address: INGOLSTADTER LANDSTRASSE contact info |
DE (NEUHERBERG) | participant | 0.00 |
| 11 |
JENLAB GMBH
Organization address
address: Nerkewitzer Strasse 18 contact info |
DE (NEUENGOENA) | participant | 0.00 |
| 12 |
MICHELSON DIAGNOSTICS LTD
Organization address
address: GRAYS FARM PRODUCTION VILLAGE contact info |
UK (ORPINGTON) | participant | 0.00 |
| 13 |
NKT PHOTONICS A/S
Organization address
address: BLOKKEN contact info |
DK (BIRKEROD) | participant | 0.00 |
| 14 |
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS
Organization address
address: College Gate, North Street contact info |
UK (ST ANDREWS FIFE) | participant | 0.00 |
| 15 |
UNIVERSITY COLLEGE LONDON
Organization address
address: Gower Street contact info |
UK (LONDON) | participant | 0.00 |
| 16 |
WEIZMANN INSTITUTE OF SCIENCE
Organization address
address: Herzel Street contact info |
IL (REHOVOT) | participant | 0.00 |
| 17 |
XVUE DESIGN DEVELOPMENT TRADE OF SOFTWARE AND HIGH TECHNOLOGY SYSTEMS LIMITED LIABILITY COMPANY
Organization address
address: SPETSON contact info |
EL (ARTEMIS) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
Biophotonics offers low-cost, non-invasive, accurate, rapid alternatives to conventional diagnostic methods and has the potential to address medical needs with early detection and to reduce the cost of healthcare. FAMOS will develop a new generation of light sources with step-changes in performance beyond the state-of-the-art to radically transform biophotonic technologies for point-of-care diagnosis and functional imaging. This will enable optical diagnostics with superior sensi-tivity, specificity, reliability and clinical utility at reduced cost, heralding an imaging renaissance in Europe.FAMOS addresses optical imaging from molecular over (sub)cellular to individual organs, with no gap in the arsenal of diagnostic tools for medical end-users. The world-class multidisciplinary FA-MOS team of 7 leading academic institutions and 10 top SMEs has unique complementary knowledge of optical coherence tomography, adaptive optics, photoacoustic tomography, coherent anti-stokes Raman scattering, multiphoton tomography as well as swept-source, diode-pumped ultrafast and tuneable nanosecond pulse lasers. Combinations of some techniques will offer multi-modal solutions to diagnostic needs that will exploit and enhance the benefits of each modality. FAMOS technologies have wide applicability, but our specific focus is on diagnosis in ophthalmol-ogy and oncology. Partnerships with leading innovative clinical users will enable preclinical evalua-tion.The objectives of FAMOS are:•tDevelop new light sources with a step-change in performance (2-3 times more compact and up to 3-4 times cheaper diode pumped Ti:sapphire, 4-10 times faster swept sources and tuneable nanosecond pulse sources)•tIntegrate these with optical imaging for a step-change in diagnosis (2-5 times better resolution cellular retinal imaging with more than 10 times larger field of view, up to 10 times enhanced penetration single source subcellular morphologic imaging, increased selectivity of intrinsic mo-lecular sensing as well as several frames per second deep tissue functional tomography•tPerform preclinical studies to demonstrate novel or improved ophthalmic and skin cancer diag-nosis establishing novel biomarkers (melanocyte shape, NADPH, melanin concentration, Hb/HbO2 as well as lipid, water and DNA/RNA concentration)•tEnable exceptional commercial opportunities for SMEs•tProvide state-of-the-art academic training